NEW YORK (360Dx) – DiaSorin on Tuesday announced a binding agreement to purchase from Siemens Healthineers its microtiter-based ELISA immunodiagnostics business and related tangible and intangible assets for €47.5 million ($55.3 million).
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.